Pentoxifylline potentiates nitric oxide production in interleukin-1β-stimulated vascular smooth muscle cells through cyclic AMP-dependent protein kinase A pathway
Na-Young Kim , Hyun-Ock Pae , Youn-Chul Kim , Chang-Kyung Choi , Joung-Sik Rim , Ho-Sub Lee , Young-Myeung Kim , Hun-Taeg Chung
{"title":"Pentoxifylline potentiates nitric oxide production in interleukin-1β-stimulated vascular smooth muscle cells through cyclic AMP-dependent protein kinase A pathway","authors":"Na-Young Kim , Hyun-Ock Pae , Youn-Chul Kim , Chang-Kyung Choi , Joung-Sik Rim , Ho-Sub Lee , Young-Myeung Kim , Hun-Taeg Chung","doi":"10.1016/S0306-3623(01)00108-2","DOIUrl":null,"url":null,"abstract":"<div><p>In the present study, we observed that pentoxifylline (PTX) significantly augmented the nitric oxide (NO) production and the iNOS gene expression by interleukin-1β (IL-1β)-stimulated vascular smooth muscle cells (VSMCs). The enhancing effects of PTX on the IL-1β-induced NO production was associated with an increased intracellular cyclic AMP (cAMP) levels, and the synergistic effects of PTX on the IL-1β-induced NO production was blocked by cAMP-dependent protein kinase A (PKA) inhibitors. PKA inhibitors, KT5720 and H89, markedly decreased the augmented expression of iNOS gene whereas ODQ, a soluble guanylate cyclase inhibitor, did not affect the enhancing effect. In addition, the pretreatment with KT5720 or H89 abolished the increased translocation of the p65 subunit of NF-κB into the nucleus by PTX in the IL-1β-stimulated VSMCs. These results suggest that enhancing effects of PTX on the iNOS gene expression in the IL-1β-stimulated VSMCs is mediated predominantly through the activation of NF-κB via cAMP-dependent PKA pathway.</p></div>","PeriodicalId":12607,"journal":{"name":"General Pharmacology-the Vascular System","volume":"35 4","pages":"Pages 205-211"},"PeriodicalIF":0.0000,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0306-3623(01)00108-2","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"General Pharmacology-the Vascular System","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0306362301001082","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17
Abstract
In the present study, we observed that pentoxifylline (PTX) significantly augmented the nitric oxide (NO) production and the iNOS gene expression by interleukin-1β (IL-1β)-stimulated vascular smooth muscle cells (VSMCs). The enhancing effects of PTX on the IL-1β-induced NO production was associated with an increased intracellular cyclic AMP (cAMP) levels, and the synergistic effects of PTX on the IL-1β-induced NO production was blocked by cAMP-dependent protein kinase A (PKA) inhibitors. PKA inhibitors, KT5720 and H89, markedly decreased the augmented expression of iNOS gene whereas ODQ, a soluble guanylate cyclase inhibitor, did not affect the enhancing effect. In addition, the pretreatment with KT5720 or H89 abolished the increased translocation of the p65 subunit of NF-κB into the nucleus by PTX in the IL-1β-stimulated VSMCs. These results suggest that enhancing effects of PTX on the iNOS gene expression in the IL-1β-stimulated VSMCs is mediated predominantly through the activation of NF-κB via cAMP-dependent PKA pathway.